B

Antibody
CTR (n=3) ME (n=3) ET-1 2.56 ± 0.18 2.00 ± 0.17 SPARC 1.10 ± 0.11 3.56 ± 0.18*** HGF 1.00 ± 0.17 3.56 ± 0.24*** A) Count of the of MKs in femur sections of control mice (CTR) and bone metastasis bearing mice (ME) after Haematoxylin & Eosin (H&E) staining of bone specimens. B) Semiquantitative analysis of MKs in bone specimens of CTR and ME mice after immunostaining with the indicated antibodies. Both in A and in B, the statistical analysis (t test) was performed on three serial section (five fields for each section were randomly selected and counted under 200x magnification) for three mice for each treatment. The tables report the means ± S.E.; ** p<0.05; *** p≤0.001 vs respective CTR mice. Representative H&E staining and immunoistochemical images are shown in Figure 2 and 3.
